JPN/573
WTO/TBT
JP Japan
  • 11 - Health care technology
2018-01-28
2017-12-01

Pharmaceutical, quasi-drug, cosmetic, medical device and regenerative medicine products (hereinafter referred to as "pharmaceuticals, etc.").

Partial amendment to the Standard for Biological Ingredients (1 page(s), in English)

The Standard for Ruminant-Derived Ingredients in the Standard for Biological Ingredients (the notification No.210 of MHLW, 2003): To delete bovine-derived "placenta" and "spleen" from the list of the parts which must not be used as source materials for manufacturing pharmaceuticals, etc., in accordance with the revision of the Standard for Ruminant-Derived Ingredients.